Quantcast

Latest epilepsy Stories

2014-08-21 16:24:57

HOUSTON, Aug. 21, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences. Rohan Hoare, Cyberonics' Chief Operating Officer, will present at the Morgan Stanley 2014 Global Healthcare Conference in New York on Tuesday, September 9, 2014 at 3:30 PM Eastern Time. The conference will be conducted in an "unplugged" format, with presentations...

2014-08-20 04:20:01

Eisai Submits Applications for Antiepilepsy Agent Fycompa Simultaneously In Europe and U.S. Seeking Indication Expansion as Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures Tokyo, Aug 20, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has submitted applications to regulatory authorities in the U.S. and Europe (the FDA and EMA respectively) for the...

2014-08-07 23:07:31

Myleeah Chapman, a sixteen year old girl in California, struggles with the serious neurological disorder, epilepsy. Family and friends are seeking donations to help pay for the medical expenses and equipment Myleeah needs to deal with the frequent and random seizures that now wrack her body on a near daily basis and Myleeah’s greatest wish is for a specially-trained service dog that will enable her to go back to school and finish her senior year of high school with her friends, please...

2014-08-05 16:27:14

SCHOFIELD, Wis., Aug. 5, 2014 /PRNewswire/ -- PuraMed BioScience(®), Inc., (OTCPink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it plans to begin testing of a new hemp-based epilepsy medication in the fourth quarter of 2014. "As we looked at the similarities between migraine and epilepsy the treatment path became obvious," said Russell Mitchell, CEO and Chairman of PuraMed BioScience. "Epilepsy and...

2014-07-31 16:29:24

AZ-002 Phase 2a Study in Patients with Epilepsy Planned for Second Half of 2014 MOUNTAIN VIEW, Calif., July 31, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its pipeline and new product development efforts. In the second half of 2014, Alexza expects to initiate a Phase 2a study of AZ-002 (Staccato(®) alprazolam), which is being developed for the management of patients with acute repetitive seizures. Additionally, Alexza has...

2014-07-30 23:14:01

With the rising popularity of “boutique surgeries” being offered by less qualified specialists, ANS has launched an awareness campaign to educate the community on the importance of choosing a neurosurgeon for an accurate diagnosis and to dismiss the idea that you only go to a neurosurgeon when surgery is needed. Morristown, NJ (PRWEB) July 30, 2014 Stroke Treatment Atlantic NeuroSurgical Specialists continues to be a leader in the war against stroke. In 2012, ANS became the first...

2014-07-28 08:30:11

An Innovative Approach That Puts Clinicians in Charge MAPLE GROVE, Minn., July 28, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that it has launched the Upsher-Smith Galaxy(TM), a new and growing suite of antiepileptic drugs (AEDs) that offers people with epilepsy consistent, affordable and accessible therapies. The current Upsher-Smith Galaxy(TM) Portfolio includes seven frequently prescribed AEDs which represent more than one out of every three...

2014-07-23 12:32:42

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243627/Generalized-Tonic-Clonic-Seizure-Global-Clinical-Trials-Review-H2-2014.htmlGeneralized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014" provides data...

2014-07-23 12:31:49

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Neurostimulation: Technologies and Global Marketshttps://www.reportbuyer.com/product/2070063/Neurostimulation-Technologies-and-Global-Markets.htmlREPORT HIGHLIGHTSThe global neurostimulation devices market is expected to reach $3.8 billion in 2013 and $4.1 billion in 2018, with a compound annual growth rate (CAGR) of 1.5%.This report provides:An overview of the global market for...

2014-07-23 08:31:01

- Brivaracetam is the newest investigational medicine to emerge from UCB's rich late-stage pipeline BRUSSELS, July 23, 2014 /PRNewswire/ -- regulated information -- UCB today announced an important advance in its research and development pipeline with positive topline results from the latest Phase 3 study with brivaracetam. This study was designed to evaluate the efficacy and safety of brivaracetam (100 and 200 mg/day, without titration) compared to placebo, as adjunctive treatment in adult...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related